New Content  edit

Loading the player...
Oral Prostacyclins in the Treatment of PAH
Share URL
Embed Code
Share by Email
Send to social websites
Report this video as inappropriate You can report this video if you think it to be inappropriate, we will review your submission soon. If your reason is not listed here, like copyright infringements, please contact us directly by email. Select your reason
Sexual Content Violent or Repulsive Content
Hateful or Abusive Content Harmful Dangerous Acts
Child Abuse Spam
When is it appropriate to consider oral prostacyclins in the PAH treatment regimen? A panel of PAH experts discusses the use of newer therapies which target the prostacyclin pathway, such as oral treprostinil and oral selexipag, and the potential role of these drugs alone or in combination with background PAH therapies. Moderated by Richard Channick, MD. Discussants: Lewis Rubin, MD, Vallerie McLaughlin, MD, and Rajan Saggar, MD.